Institut Mérieux
Institut Mérieux is contributing its experience in biology to improve medicine and public health across the globe. Its three bio-industrial companies (bioMérieux, Transgene and Mérieux NutriSciences), working alongside its entity devoted to investment in healthcare (Mérieux Equity Partners), have contributed to major advances in medicine and public health.
2.6%
OF GAV*
€1.0bn
shareholding value
10.0%
economic rights
5.3%
voting rights
* As of 31 December 2025